Randomised controlled trial of effect of feedback on general practitioners' prescribing in Australia.

PubWeight™: 2.11‹?› | Rank: Top 2%

🔗 View Article (PMC 27749)

Published in BMJ on February 20, 1999

Authors

D L O'Connell1, D Henry, R Tomlins

Author Affiliations

1: Discipline of Clinical Pharmacology, Faculty of Medicine and Health Sciences, University of Newcastle, New South Wales, Australia. doconnel@mail.newcastle.edu.au

Articles citing this

Does continuing medical education in general practice make a difference? BMJ (1999) 4.40

Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. BMJ (2003) 4.18

The impact of a general practice group intervention on prescribing costs and patterns. Br J Gen Pract (2002) 2.90

The Department of Health's "two week standard" for bowel cancer: is it working? Gut (2004) 2.88

General practitioners with a special clinical interest: a model for improving respiratory disease management. Br J Gen Pract (2002) 1.80

Use of behavioral economics and social psychology to improve treatment of acute respiratory infections (BEARI): rationale and design of a cluster randomized controlled trial [1RC4AG039115-01]--study protocol and baseline practice and provider characteristics. BMC Infect Dis (2013) 1.23

Role of diagnostic labeling in antibiotic prescription. Can Fam Physician (2001) 1.20

Improving doctors' prescribing behaviour through reflection on guidelines and prescription feedback: a randomised controlled study. Qual Health Care (2000) 1.14

Management of menorrhagia in primary care-impact on referral and hysterectomy: data from the Somerset Morbidity Project. J Epidemiol Community Health (2000) 1.13

Quality use of medicines in the community: the Australian experience. Br J Clin Pharmacol (2000) 1.12

Prescription audit adjunct to rational pharmacotherapy education improves prescribing skills of medical students. Eur J Clin Pharmacol (2005) 1.10

Improving test ordering in primary care: the added value of a small-group quality improvement strategy compared with classic feedback only. Ann Fam Med (2004) 1.00

The application of prescribing indicators to a primary care prescription database in Ireland. Eur J Clin Pharmacol (2005) 0.94

National Prescribing Service: creating an implementation arm for national medicines policy. Br J Clin Pharmacol (2005) 0.88

Effect of mailed feedback on drug prescribing profiles in general practice: a seven-year longitudinal study in Storstrøm County, Denmark. Ups J Med Sci (2010) 0.85

Developing an active implementation model for a chronic disease management program. Int J Integr Care (2013) 0.85

Irrational prescribing of over-the-counter (OTC) medicines in general practice: testing the feasibility of an educational intervention among physicians in five European countries. BMC Fam Pract (2014) 0.78

Prescribing Data in General Practice Demonstration (PDGPD) project--a cluster randomised controlled trial of a quality improvement intervention to achieve better prescribing for chronic heart failure and hypertension. BMC Health Serv Res (2012) 0.76

The effect of a physician-targeted intervention on metoclopramide prescribing practice. Ther Clin Risk Manag (2011) 0.75

Effect of audit and feedback with peer review on general practitioners' prescribing and test ordering performance: a cluster-randomized controlled trial. BMC Fam Pract (2017) 0.75

Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban Australia. Eur J Clin Pharmacol (2003) 0.75

Pharmacoepidemiologic research in Australia: challenges and opportunities for monitoring patients with rheumatic diseases. Clin Rheumatol (2009) 0.75

Articles cited by this

No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ (1995) 22.08

Effects of feedback of information on clinical practice: a review. BMJ (1991) 8.19

What can PACT tell us about prescribing in general practice? BMJ (1997) 5.67

Single and combined strategies for implementing changes in primary care: a literature review. Int J Qual Health Care (1994) 5.27

Effectiveness of notification and group education in modifying prescribing of regulated analgesics. CMAJ (1996) 3.93

Basing prescription drug payment on economic analysis: the case of Australia. Health Aff (Millwood) (1992) 3.15

Audit reviewed: does feedback on performance change clinical behaviour? J R Coll Physicians Lond (1985) 2.62

Improving drug prescribing in a primary care practice. Med Care (1984) 2.48

Influencing behavior of physicians ordering laboratory tests: a literature study. Med Care (1993) 1.95

Influence of simple computerized feedback on prescription charges in an ambulatory clinic. A randomized clinical trial. Med Care (1986) 1.58

Changing clinical practice. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med (1994) 1.54

Cost effectiveness of two interventions for reducing outpatient prescribing costs. DICP (1989) 1.44

Reduction of polypharmacy by feedback to clinicians. J Gen Intern Med (1991) 1.41

The effect of an education and feedback intervention on group-model and network-model health maintenance organization physician prescribing behavior. Med Care (1995) 0.96

Rising prescription drug costs: whose responsibility? Med J Aust (1997) 0.96

Articles by these authors

(truncated to the top 100)

Coverage by the news media of the benefits and risks of medications. N Engl J Med (2000) 7.50

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. Lancet (1998) 4.54

Promoting cost effective prescribing. BMJ (1995) 3.46

Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations. Intern Med J (2005) 3.08

Comparing treatments. BMJ (1995) 3.02

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med (1995) 2.88

Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. N Engl J Med (1983) 2.72

Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med (2000) 2.68

Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). J Clin Microbiol (2000) 2.63

Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. BMJ (1995) 2.61

The effects of information framing on the practices of physicians. J Gen Intern Med (1999) 2.52

Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol (2001) 2.27

Disease mongering: expanding the boundaries of treatable disease. Intern Med J (2008) 2.19

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. J Infect Dis (1999) 1.87

Autologous transfusion techniques: a systematic review of their efficacy. Transfus Med (2004) 1.84

Association between availability of non-prescription beta 2 agonist inhalers and undertreatment of asthma. BMJ (1993) 1.76

Ethics and evidence based medicine. BMJ (1998) 1.74

A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med (1996) 1.64

Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Int J Syst Evol Microbiol (2001) 1.61

Catecholamines in fetal and newborn rat brain. J Neurochem (1973) 1.55

A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression. Cancer Invest (1998) 1.51

Clinical comparison of isolator and BACTEC 660 resin media for blood culture. J Clin Microbiol (1990) 1.51

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. Br J Cancer (2010) 1.46

Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc (2000) 1.44

Cloning and characterization of a Na+-driven anion exchanger (NDAE1). A new bicarbonate transporter. J Biol Chem (2000) 1.42

Trial of streptokinase in ischaemic stroke. Lancet (1995) 1.42

Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis (1995) 1.41

Spatiotemporal evolution of Poiseuille-Rayleigh-Bénard flows in binary fluids with Soret effect under initial pulselike disturbances. Phys Rev E Stat Nonlin Soft Matter Phys (2009) 1.40

Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study. Clin Infect Dis (2000) 1.40

Patterns of psychopathology among urban poor children: comorbidity and aggression effects. J Consult Clin Psychol (1996) 1.34

Comparative evaluation of four systems for determining susceptibility of gram-positive organisms. J Clin Microbiol (1986) 1.32

Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev (2002) 1.30

Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy. Kidney Int (1998) 1.22

An intervention to improve the hospital discharge summary. J Med Educ (1988) 1.17

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer. J Clin Oncol (1989) 1.16

Physiological analysis of mutants of Saccharomyces cerevisiae impaired in sulphate assimilation. J Gen Microbiol (1992) 1.14

Voltage-dependent sodium channels are expressed in nonspiking retinal bipolar neurons. J Neurosci (2001) 1.14

In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents. Antimicrob Agents Chemother (1985) 1.13

Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev (2000) 1.12

Toxic methemoglobinemia: a rare but serious complication of transesophageal echocardiography. Can J Cardiol (1998) 1.07

Benzodiazepine use as a cause of cognitive impairment in elderly hospital inpatients. J Gerontol A Biol Sci Med Sci (1995) 1.06

Literacy and self-reported educational levels in relation to Mini-mental State Examination scores. Fam Med (1996) 1.04

The effects of increased rehabilitation therapy after brain injury: results of a prospective controlled trial. Clin Rehabil (2001) 1.03

Late complications involving the ascending aorta after cardiac surgery: recognition and management. Am Heart J (1991) 1.03

Technologies to minimize blood transfusion in cardiac and orthopedic surgery. Results of a practice variation survey in nine countries. International Study of Peri-operative Transfusion (ISPOT) Investigators. Int J Technol Assess Health Care (1999) 1.00

Psychopathology in non-clinically referred sexually abused children. J Am Acad Child Adolesc Psychiatry (1998) 0.99

Economic evaluation of pharmaceuticals: what are reasonable standards for clinical evidence--the Australian experience. Br J Clin Pharmacol (1997) 0.96

C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat. Diabetologia (2001) 0.96

Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase. Circulation (1998) 0.93

Psychiatric disorders in sexually abused children. J Am Acad Child Adolesc Psychiatry (1994) 0.93

Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy. Int J Clin Pract (2004) 0.93

Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy. Diabetes Obes Metab (2002) 0.91

Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators. J Infect Dis (2000) 0.91

Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis (1995) 0.91

Patterns of analgesic and anti-inflammatory medicine use by Australian veterans. Intern Med J (2007) 0.90

Meta-analysis workshop in upper gastrointestinal hemorrhage. Gastroenterology (1991) 0.90

Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes. Diabetes Obes Metab (2002) 0.90

Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression. Am J Physiol Renal Physiol (2001) 0.89

Extinction versus credibility in the desensitization of speech anxiety. J Consult Clin Psychol (1977) 0.89

Cognitive behavioral treatment for sexually abused children suffering post-traumatic stress: preliminary findings. J Am Acad Child Adolesc Psychiatry (1990) 0.88

Prescription drug utilization following patient co-payment changes in Australia. Pharmacoepidemiol Drug Saf (1996) 0.88

Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action. J Clin Invest (1998) 0.87

Evaluating a cognitive/ecological program for the prevention of aggression among urban children. Am J Prev Med (1997) 0.86

Current problems with non-specific COX inhibitors. Curr Pharm Des (2000) 0.86

Comparison of agar dilution, microdilution, and disk elution methods for measuring the synergy of cefotaxime and its metabolite against anaerobes. J Clin Microbiol (1986) 0.86

Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide. J Clin Pharmacol (1997) 0.85

National school teachers' knowledge of asthma and its management. Ir J Med Sci (1999) 0.85

Sexually abused children at high risk for post-traumatic stress disorder. J Am Acad Child Adolesc Psychiatry (1992) 0.84

Stability of two-layer shear-thinning film flows. Phys Rev E Stat Nonlin Soft Matter Phys (2013) 0.84

Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree. J Investig Dermatol Symp Proc (1999) 0.82

Diclofenac hepatitis. Gut (1991) 0.82

Attitudes of Japanese students toward people with intellectual disability. J Intellect Disabil Res (2002) 0.82

Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation. Neuroreport (1993) 0.81

Health status instruments / utilities. J Rheumatol (1995) 0.81

Use of high-pressure liquid chromatography for quantitative structure-activity relationship studies of sulfonamides and barbiturates. J Med Chem (1976) 0.80

Lymphatic filariasis: detection of circulating and urinary antigen and differences in antibody isotypes complexed with circulating antigen between symptomatic and asymptomatic subjects. Clin Exp Immunol (1988) 0.80

Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group. Chest (1998) 0.79

Implications of the Australian guidelines for the United States. Health Aff (Millwood) (1992) 0.79

Nitric oxide participates in excitotoxic mechanisms induced by chemical hypoxia. Brain Res (1994) 0.78

Status epilepticus. Recent experience at the Port-of-Spain General Hospital, Trinidad. West Indian Med J (1992) 0.78

Functional and oximetric assessment of patients after lung reduction surgery. J Thorac Cardiovasc Surg (1997) 0.78

Published pharmacoeconomic analyses: science or marketing? Intern Med J (2003) 0.78

Neutrophil-derived relaxing factor relaxes vascular smooth muscle through a cGMP-mediated mechanism. Life Sci (1990) 0.77

Assessing perceived agency adherence to the values of community inclusion: implications for staff satisfaction. Am J Ment Retard (1998) 0.77

Determination of fat in olestra-containing savory snack products by capillary gas chromatography. J AOAC Int (1998) 0.77

Cost-effectiveness analysis in the treatment of hypertension: a medical view. Clin Exp Hypertens (1999) 0.77

Cloning and nucleotide sequence of a cDNA encoding a major fucoxanthin-, chlorophyll a/c-containing protein from the chrysophyte Isochrysis galbana: implications for evolution of the cab gene family. Plant Mol Biol (1994) 0.77

The possible role of the catecholamines of the corpora in penile erection. J Urol (1979) 0.77

Comparison of standard and chlorhexidine-derivative topical antibacterial agents on the infected burned rat wound. Burns Incl Therm Inj (1988) 0.76

Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension. J Pediatr (1993) 0.76

Office-based arthroscopic synovectomy of the wrist in rheumatoid arthritis. Arthroscopy (2001) 0.76

The efficacy and safety of terazosin for the treatment of symptomatic BPH. Prostate (1991) 0.76

Prediction of response to recombinant human erythropoietin (r-HuEPO/epoetin-alpha) therapy in cancer patients. Blood (1995) 0.76

Systematic reviews provide information not contained in traditional narrative reviews. BMJ (1997) 0.75

A novel cyclic nucleotide-gated ion channel enriched in synaptic terminals of isotocin neurons in zebrafish brain and pituitary. Neuroscience (2009) 0.75

Meta-analysis-its role in assessing drug safety. Pharmacoepidemiol Drug Saf (1999) 0.75

Meta-analysis of risk of gastrointestinal complications with NSAIDs. Authors should not have included data from one study. BMJ (1997) 0.75

Inhibition of the catalytic subunit of ram sperm adenylate cyclase by adenosine. Biochem Biophys Res Commun (1986) 0.75

Scuba divers at risk of decompression sickness. Med J Aust (1990) 0.75

NSAIDs and risk of upper gastrointestinal bleeding. Lancet (1991) 0.75